OrsoBio, Inc. (“OrsoBio” or “the Company”), a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, today announced the publication in Nature ...

There have been some interesting failures recently in Alzheimer’s trials. Two are notable because they’re aimed outside the usual amyloid zone. Novo Nordisk (NVO) recently reported that semaglutide ...

n = 345 adults seeking web based ADHD assessment (predominantly female; mean age = 35). Sensitivity = 80.6% and Positive Predictive Value = 94.9%. False positive rate = 12% versus 56% for the clinical ...

Basic psychological need theory posits that satisfying basic psychological needs (autonomy, competence, relatedness) is connected to overall well-being and physiological health, including sleep. The ...

IRVING, Texas, Aug. 15, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study ...

A pair of CROs from opposite sides of the Atlantic Ocean are merging to form a global organization. Evestia Clinical and Atlantic Research Group are joining forces to bring clients expertise in ...

Merriam, Kansas-based Advent Health Shawnee Mission Hospital has filed a lawsuit against Blue Cross and Blue Shield of Kansas City for artificial intelligence-driven technology that the provider said ...

About The Study: In an average-risk colorectal cancer screening population, a blood-based test demonstrated acceptable accuracy for colorectal cancer detection, but detection of advanced precancerous ...

Beta-CORRECT study to be presented at ASCO 2025 confirms the clinical utility of the molecular residual disease (MRD) test, Oncodetect™, for recurrence monitoring in stage II–IV colorectal cancer ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England Journal ...